Airing weekdays at 7:30 A.M. on

Airing weekdays at 7:30 A.M. on

There are approximately 7,000 known rare diseases, but only 5% of them have an approved treatment. Learn how early intervention, proper management strategies, and clinical trials are key for rare disease patients.

Friedreich’s Ataxia (FA) is a progressive and debilitating neurological disorder. FA is the most common inherited ataxia and is caused by a mutation on both copies of the FXN gene which makes frataxin protein, which is needed for proper function of the brain, nervous system, and heart.

Clinical trials are an opportunity for patients to receive promising new therapies, but they can be difficult to navigate. Learn how The Leukemia & Lymphoma Society’s Clinical Trial Support Center is helping guide patients.

BioTE Medical is a leader in precision and preventive medicine. They create patient-centric strategies that optimize hormones for women and men.

The Oxford Gold Group was founded on the belief that everyone should have the opportunity to afford and benefit from owning precious metals. They tailor investment strategies for each investor based on their specific needs.

TruSculpt iD and truSculpt flex offer you a total body solution to remove fat, renew skin, and rebuild muscle.

Comments

comments